Updating the International Standards for Tuberculosis Care: Entering the era of molecular diagnostics

Annals of the American Thoracic Society

Volumn 11, Issue 3, 2014, Pages 286-295

  Hopewell, Philip C ^a   Fair, Elizabeth L ^a   Uplekar, Mukund ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Diagnosis; Drug resistance; Human immunode ficiency virus infection; Treatment; Tuberculosis

Indexed keywords

COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; BACTERIUM DETECTION; CLINICAL PROTOCOL; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL LITERATURE; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 84898752301     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201401-004AR     Document Type: Article

References (35)

1. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis 2006;6:710-725. (Pubitemid 44740086)
2. World Health Organization. International Standards for Tuberculosis Care [Internet]. [accessed 2014 Jan 3]. Available from: www.who.int/tb/publications/ 2006/istc-report.pdf
3. International Standards for Tuberculosis Care, 3rd ed. 2014. Available from: www.istcweb.org
4. World Health Organization. Rapid implementation of the Xpert MTB/ RIF diagnostic test: technical and operational "how-to": practical considerations. Geneva: World Health Organization; 2011.
5. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013;1:CD009593.
6. World Health Organization. The use of the Xpert MTB/RIF assay for the detection of pulmonary, extrapulmonary, tuberculosis and rifampicin resistance in adults and children. Geneva: World Health Organization; 2013.
7. Lönnroth K, Raviglione MC. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008;29: 481-491.
8. World Health Organization. Global tuberculosis report, 2013. Geneva: World Health Organization; 2013.
9. Weyer K, Mirzayev F, Migliori GB, Van Gemert W, D'Ambrosio L, Zignol M, Floyd K, Centis R, Cirillo DM, Tortoli E, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013;42:252-271.
10. World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. Geneva: World Health Organization; 2008.
11. Legido-Quigley H, Montgomery CM, Khan P, Atun R, Fakoya A, Getahun H, Grant AD. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health 2012;18:199-211.
12. World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization; 2013.
13. World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Geneva: World Health Organization; 2012.
14. Malmborg R, Mann G, Squire SB. A systematic assessment of the concept and practice of public-private mix for tuberculosis care and control. Int J Equity Health 2011;10:49.
15. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: a 2011 update. Geneva: World Health Organization; 2011.
16. International Standards for Tuberculosis Care 2nd ed. 2009 [accessed 2014 Jan 3]. Available from: www.currytbcenter.ucsf.edu/international/istc-report
17. World Health Organization. Handbook for guideline development. Geneva: World Health Organization; 2012.
18. Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Granich R, Dewan PK, Lal SS, Lonnroth K, et al. Improving tuberculosis control through public-private collaboration in India: literature review. BMJ 2006;332:574-578.
19. Langendam MW, van der Werf MJ, Huitric E, Manissero D. Prevalence of inappropriate tuberculosis treatment regimens: a systematic review. Eur Respir J 2012;39:1012-1020.
20. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 2001;358: 912-916. (Pubitemid 32900580)
21. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8:15.
22. Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis 2009;9:91.
23. Davis J, Katamba A, Vasquez J, Crawford E, Sserwanga A, Kakeeto S, Kizito F, Dorsey G, den Boon S, Vittinghoff E, et al. Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services. Am J Respir Crit Care Med 2011;184:362-367.
24. World Health Organization. Involving private practitioners in tuberculosis control: issues, interventions, and emerging policy framework. Geneva: World Health Organization; 2001.
25. Grenier J, Pinto L, Nair D, Steingart K, Dowdy D, Ramsay A, Pai M. Widespread use of serological tests for tuberculosis: data from 22 high-burden countries. Eur Respir J 2012;39:502-505.
26. World Health Organization. Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement. Geneva: World Health Organization; 2011.
27. Hopewell PC, Pai M. Tuberculosis, vulnerability, and access to quality care. JAMA 2005;293:2790-2793. (Pubitemid 40965092)
28. World Health Organization. Guidance on ethics of tuberculosis prevention, care, and control. Geneva: World Health Organization; 2010.
29. Ukwaja KN, Alobu I, Abimbola S, Hopewell PC. Household catastrophic payments for tuberculosis care in Nigeria: incidence, determinants, and policy implications for universal health coverage. Infect Dis Poverty 2013;2:21.
30. Ukwaja KN, Alobu I, Lgwenyi C, Hopewell PC. The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria. PLoS ONE 2013;8: e73134.
31. World Health Organization. Implementing the Stop TB strategy: a handbook for national tuberculosis control programmes. Geneva: World Health Organization; 2008.
32. International Union against Tuberculosis and Lung Disease. Management of tuberculosis: guide to the essentials of good clinical practice. Paris: International Union against Tuberculosis and Lung Disease; 2010.
33. World Health Organization. Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations. Geneva: World Health Organization; 2012.
34. Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, D'Ambrosio L, Centis R, Sotgiu G, Menegale O, et al. European Union standards for tuberculosis care. Eur Respir J 2012;39: 807-819.
35. Pai M, Das J. Management of tuberculosis in India: time for a deeper dive into quality. Natl Med J India 2013;26:65-68.